The FDA recently approved a new drug called Aduhelm for the treatment of Alzheimer’s disease. This drug works by removing amyloid plaques from the brain, which are believed to contribute to the development of the disease. However, the drug’s approval has been controversial, as some experts have questioned its efficacy.
